The 63rd session of the United Nations Commission on Narcotic Drugs (CND) in Vienna this week laid bare deep divisions in the international community over the World Health Organization (WHO) cannabis scheduling recommendations.
Rather than voting on recommendations that would have far-reaching implications for the global cannabis industry, the CND postponed the vote to December.
The delay underscores the difficulty in reaching agreements on cannabis policy on a level that transcends national borders.
“Medical cannabis is more mainstream than ever in places like Canada and the USA. However, internationally the challenge ahead for access becomes clear,” Michael Krawitz, executive director of Veterans for Medical Cannabis Access told Marijuana Business Daily.
The Michigan-based veterans organization helped coordinate civil society contributions to the WHO cannabis review process.
“Countries like Indonesia and Russia sound like North American drug warriors from back in the 1980s, and if the USA timeline works as a model, we are just beginning a decades-long process.”
A forced vote this week would have likely resulted in a negative result.Given the current level of disagreement, postponing the vote was the best outcome for the recommendations to stand any chance of approval.
“This is a very important but, at the same time, very sensitive issue because of the divergent opinions – not only among the states but among the people in general,” CND Chair Mansoor Ahmad Khan said.
Published: March 07, 2020
The post Postponed vote on WHO cannabis recommendations reveals international disagreements appeared first on L.A. Cannabis News.